-
June 19, 2013
-
Haemonetics Announces Next Steps in Manufacturing Transformation
View details
-
June 5, 2013
-
Haemonetics to Present at The William Blair 33rd Annual Growth Stock Conference
View details
-
May 29, 2013
-
Haemonetics And SABM Announce Research Grant
View details
-
May 24, 2013
-
Haemonetics to Present at The Jefferies 2013 Global Healthcare Conference
View details
-
May 24, 2013
-
Haemonetics partners with SABM to fund Research Grant
View details
-
May 23, 2013
-
Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
View details
-
May 1, 2013
-
Key acquisitions advance our strategy for entry into whole blood collection
View details
-
May 1, 2013
-
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance
View details
-
May 1, 2013
-
Haemonetics Completes Hemerus Medical, LLC Acquisition
View details
-
April 30, 2013
-
Arryx, Inc
View details
-
April 24, 2013
-
Haemonetics Sets Date for Investor/Analyst Meeting
View details
-
April 1, 2013
-
Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013
View details
-
March 29, 2013
-
Rebranding of products acquired from Pall
View details
-
March 4, 2013
-
Haemonetics partners with National Patient Safety Foundation
View details
-
February 25, 2013
-
UPDATE: North America Field Action Announcement
View details
-
February 25, 2013
-
Haemonetics to Present at The Raymond James Institutional Investors Conference
View details
-
February 14, 2013
-
Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety
View details
-
February 13, 2013
-
Haemonetics to Present at Citi 2013 Global Healthcare Conference
View details
-
February 6, 2013
-
Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference
View details
-
January 30, 2013
-
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
View details
-
January 9, 2013
-
Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013
View details
-
January 4, 2013
-
Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference
View details